Cesca Therapeutics Reports First Quarter Fiscal 2015 Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/14/2026
- S&P 500 notches record-high close as rate-hike worries ease
- Oil settles down 2% on weak demand outlook, hefty US crude build
- BofA lifts server CPU TAM to $210bn+ on the rise of AI agents
- Burry doubles down on Nebius short after stock surges 34% on earnings
- JPMorgan gets bullish on Salesforce, says concerns are "overblown"
Cesca Therapeutics (KOOL) Narrows Q1 Loss
November 13, 2014 4:13 PM ESTCesca Therapeutics (NASDAQ: KOOL) reported Q1 EPS of ($0.08), versus ($0.14) reported last year. Revenue for the quarter came in at $3.7 million, versus $3.6 million reported last year.
For earnings history and earnings-related data on Cesca Therapeutics (KOOL) click here.
... More
